Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mercator Medical S.A. (MRC.WA)
Kraków, PL
Mercator Medical S.A., operating with its subsidiaries, is a key player in the manufacturing and international supply of essential disposable medical provisions. Their primary offerings encompass a broad spectrum of medical gloves, including surgical, protective, sterile examination, and household types, alongside various wound dressings and products made from non-woven fabrics. The company's extensive inventory also features a comprehensive range of single-use apparel like caps, face masks, surgical gowns, shoe covers, staff shirts, sleeve protectors, and patient gowns. Furthermore, Mercator Medical provides specialized surgical items such as drape sheets, unique sterile drapes with non-adhesive openings, complete surgical kits, and a variety of accessories like apparatus and table covers, limb protectors, camera covers, adhesive instrument pockets, and self-adhesive nonwoven tapes. These products are sold under a strong collection of brands, including nitrylex, opero, MERCATOR, Ansell, dermagel, santex, comfort, vinylex, iNtouch, ambulance, and ideal. Their customer base is diverse, spanning medical clients such as healthcare facilities, industrial settings requiring medical supplies, retail chains, and pharmaceutical wholesalers, as well as a wide array of other sectors including beauty, hospitality (hotels, restaurants, catering), cleaning services, agri-food, automotive, home and garden, education, and general retail. Established in 1989, Mercator Medical S.A. is based in Kraków, Poland, and functions as a subsidiary of Anabaza RAIF V.C.I.C. Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.91% | -0.54% | +16.47% | +36.36% | +39.45% | +40.15% | +25.42% | +27.88% | -77.15% | +261.80% | +278.84% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+5.8% Q1'26: -1.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-43.0% Q1'26: -55.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-1.8% Q1'26: -5.3% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-2.5% Q1'26: +5.3% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-2.0% Q1'26: +4.2% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-1.8% ★ Q1'26: -1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.58× ★ Q1'26: 0.37× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
226.59M
est: 222.00M (+2.1%)
|
263.59M
est: 258.20M (+2.1%)
|
300.76M
est: 312.00M (-3.6%)
|
420.41M
est: 402.70M (+4.4%)
|
540.33M
est: 541.20M (-0.2%)
|
1.83B
est: 1.90B (-3.7%)
|
1.73B
est: 2.07B (-16.4%)
|
542.51M
est: 552.08M (-1.7%)
|
469.06M
est: 376.62M (+24.5%)
|
542.69M
est: 485.34M (+11.8%)
|
574.18M
est: 687.57M (-16.5%)
|
| EBITDA |
18.89M
est: 20.21M (-6.5%)
|
26.98M
est: 23.50M (+14.8%)
|
17.02M
est: 28.40M (-40.1%)
|
28.27M
est: 36.66M (-22.9%)
|
28.10M
est: 49.26M (-43.0%)
|
1.06B
est: 173.30M (+514.0%)
|
497.08M
est: 187.99M (+164.4%)
|
-159.75M
est: 50.25M (-417.9%)
|
-51.40M
est: 34.28M (-249.9%)
|
-4.71M
est: -9.67M (+51.3%)
|
14.56M
est: -13.69M (+206.3%)
|
| EBIT |
12.19M
est: 13.53M (-9.9%)
|
19.45M
est: 15.74M (+23.6%)
|
7.67M
est: 19.02M (-59.7%)
|
13.54M
est: 24.55M (-44.8%)
|
9.62M
est: 32.99M (-70.8%)
|
1.04B
est: 116.04M (+800.1%)
|
477.34M
est: 125.88M (+279.2%)
|
-185.88M
est: 33.65M (-652.4%)
|
-73.52M
est: 22.96M (-420.3%)
|
-23.50M
est: -28.15M (+16.5%)
|
-14.21M
est: -39.88M (+64.4%)
|
| Net Income |
10.27M
est: 14.37M (-28.5%)
|
13.90M
est: 13.15M (+5.8%)
|
4.93M
est: 4.69M (+4.9%)
|
7.47M
est: 11.17M (-33.2%)
|
-2.03M
est: -939.0K (-116.3%)
|
930.19M
est: 871.18M (+6.8%)
|
446.87M
est: 713.53M (-37.4%)
|
-189.62M
est: -5.84M (-3,149.0%)
|
-19.68M
est: -54.69M (+64.0%)
|
51.05M
est: 19.50M (+161.8%)
|
28.59M
est: 31.19M (-8.3%)
|
| SGA |
11.08M
est: 30.44M (-63.6%)
|
11.30M
est: 35.40M (-68.1%)
|
14.22M
est: 42.78M (-66.8%)
|
19.73M
est: 55.22M (-64.3%)
|
25.90M
est: 74.21M (-65.1%)
|
38.48M
est: 261.05M (-85.3%)
|
61.63M
est: 283.18M (-78.2%)
|
61.94M
est: 75.70M (-18.2%)
|
126.70M
est: 51.64M (+145.3%)
|
132.78M
est: 85.02M (+56.2%)
|
121.32M
est: 120.45M (+0.7%)
|
| EPS |
1.19
est: 1.53 (-22.2%)
|
1.50
est: 1.40 (+7.1%)
|
0.47
est: 0.50 (-6.0%)
|
0.71
est: 1.19 (-40.3%)
|
-0.19
est: -0.10 (-90.0%)
|
88.66
est: 92.78 (-4.4%)
|
44.15
est: 75.99 (-41.9%)
|
-19.41
est: -0.62 (-3,022.7%)
|
-2.05
est: -5.82 (+64.8%)
|
5.44
est: 2.12 (+157.2%)
|
3.10
est: 3.38 (-8.4%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | B | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 1/5 | 5/5 |
| 2026-06-01 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-25 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 3/5 | 4/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dariusz Krezymon | Member of the Management Board & President of the Management Board at Mercator Medical | — | male |
| Malgorzata Biela | Chief Accountant | — | — |
| Mariusz Popek | Chief Financial Officer & Member of Management Board | — | male |
| Monika Zyznowska | President of the Board | — | female |
| Piotr Solorz | Secretary of Supervisory Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRC.WA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
